FENC Stock Earnings: Fennec Pharmaceuticals Misses EPS, Beats Revenue for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

FENC stock results show that Fennec Pharmaceuticals missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.

The post FENC Stock Earnings: Fennec Pharmaceuticals Misses EPS, Beats Revenue for Q4 2023 appeared first on InvestorPlace.

• The #1 AI Investment Might Be This Company You’ve Never Heard Of
• “America’s Top Trader” Issues A.I. Code Red: Act Now or Miss Out
• It doesn’t matter if you have $500 or $5 million. Do this now.